Fingerprint
Dive into the research topics of 'A double-blind randomized discontinuation phase-ii study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: Eastern cooperative oncology group study E2501'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically